Telegraph Hill Partners is a venture capital firm investing in life sciences, medical device, and healthcare technology companies.
Business Model:
Revenue: $18.8M
Employees: 2-10
Address: Suite 601
City: San Francisco
State: CA
Zip: 94108
Country: US
Telegraph Hill Partners is a venture capital firm that invests behind technology leaders in the life science, medical devices, and healthcare industries. THP was founded in 2001 by J. Matthew Mackowski, Robert Shepler, Dr. Thomas Raffin, and Deval Lashkari, and is headquartered in San Francisco, California.
Contact Phone:
+14157656980
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2022 | Emerging Therapy Solutions | Venture Round | 3M |
9/2015 | Precision NanoSystem | Series A | 0 |
8/2019 | Emerging Therapy Solutions | Venture Round | 1M |
5/2008 | Freedom Innovations LLC. | Funding Round | - |
11/2021 | Cell Microsystems | Venture Round | 12.7M |
9/2007 | LDR Holding | Series C | 0 |
1/2007 | Althea Technologies | Series C | 23M |
9/2019 | Specific Diagnostics | Equity | 12.5M |
6/2006 | Asuragen | Series A | 49M |
3/2019 | Invisalert Solutions | Venture Round | 10M |
1/2011 | PneumRx | Venture Round | 0 |
12/2010 | Estech | Series D | 8.5M |
6/2009 | Estech | Venture Round | 0 |
3/2007 | PneumRx | Series B | 0 |
8/2017 | RareCyte | Venture Round | 30M |
10/2007 | AngioScore | Series E | 30M |
4/2006 | AngioScore | Series D | 30M |
12/2007 | Asuragen | Series B | 18.5M |
9/2018 | Akoya Biosciences | Venture Round | 24.5M |
12/2019 | Akoya Biosciences | Equity | 50M |
7/2017 | Akoya Biosciences | Venture Round | 9M |
1/2008 | Confirma | Series C | 0 |
1/2018 | Carterra | Venture Round | 10M |
7/2004 | Accumetrics | Series B | 0 |
12/2008 | Estech | Venture Round | 0 |
6/2022 | Mosaic Biosciences | Venture Round | 11.4M |
12/2020 | Carterra | Venture Round | 8.1M |
10/2016 | TrakCel | Venture Round | - |
4/2010 | AltheaDx | Series A | - |
5/2020 | Nivagen Pharmaceuticals, Inc. | Venture Round | 16M |
6/2018 | Precision NanoSystem | Series B | 6M |
3/2017 | Medpricer | Venture Round | - |
8/2012 | RareCyte | Venture Round | - |
1/2022 | Excellos | Growth | 15M |
4/2019 | Nimble Therapeutics | Series A | 10M |
1/2003 | Estech | Series B | 5M |
11/2017 | Aquaro | Series A | 9.8M |
1/2020 | Carterra | Venture Round | 6M |
6/2022 | Mosaic Biosciences | Venture Round | 0 |
1/2022 | Excellos | Funding Round | 0 |
11/2021 | Cell Microsystems | Venture Round | 0 |
12/2020 | Carterra | Venture Round | 0 |
5/2020 | Nivagen Pharmaceuticals, Inc. | Venture Round | 0 |
1/2020 | Carterra | Venture Round | 0 |
12/2019 | Akoya Biosciences | Series D | 0 |
9/2019 | Specific Diagnostics | Venture Round | 0 |
8/2019 | Emerging Therapy Solutions | Venture Round | 0 |
4/2019 | Nimble Therapeutics | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|